FDA ALERT [5/2006]
A rare, but serious form of kidney failure
has been associated with the use of oral sodium phosphate (OSP)
products (e.g., Fleet Phospho-soda solution, Fleet Accu-Prep
solution, and Visicol tablets) for bowel cleansing. No cases of
kidney failure have been associated with a recently approved
OSP product (OsmoPrep tablets) for bowel cleansing.
This information reflects FDA’s preliminary
analysis of data concerning this drug. FDA is
considering, but has not reached a final
conclusion about, this information. FDA intends
to update this sheet when additional
information or analyses become available.
